125 related articles for article (PubMed ID: 559938)
21. Antigen presentation by Hodgkin's disease cells.
Fisher RI; Cossman J; Diehl V; Volkman DJ
J Immunol; 1985 Nov; 135(5):3568-71. PubMed ID: 3876389
[TBL] [Abstract][Full Text] [Related]
22. CD21 augments antigen presentation in immune individuals.
Boackle SA; Holers VM; Karp DR
Eur J Immunol; 1997 Jan; 27(1):122-9. PubMed ID: 9022008
[TBL] [Abstract][Full Text] [Related]
23. Correlation between immune complexes and prognostic factors in Hodgkin's disease.
Amlot PL; Pussell B; Slaney JM; Williams BD
Clin Exp Immunol; 1978 Feb; 31(2):166-73. PubMed ID: 648026
[TBL] [Abstract][Full Text] [Related]
24. Tissue culture studies in Hodgkin's disease: Morphologic, cytogenetic, cell surface, and enzymatic properties of cultures derived from splenic tumors.
Long JC; Zamecnik PC; Aisenberg AC; Atkins L
J Exp Med; 1977 Jun; 145(6):1484-500. PubMed ID: 68093
[TBL] [Abstract][Full Text] [Related]
25. Defective in vitro antibody production in response to pokeweed mitogen and influenza antigen in patients with Hodgkin's disease.
Sigfusson A; Babbage JW; Souhami RL
Clin Exp Immunol; 1985 May; 60(2):396-402. PubMed ID: 4006304
[TBL] [Abstract][Full Text] [Related]
26. Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis.
Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
N Engl J Med; 1989 Mar; 320(11):689-95. PubMed ID: 2537928
[TBL] [Abstract][Full Text] [Related]
27. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
Fuks Z; Strober S; Kaplan HS
N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
[TBL] [Abstract][Full Text] [Related]
28. [Circulating immune complexes in the serum of patients with Hodgkin's disease].
Berényi E; Kávai M; Pálkövi E; Szegedi G
Orv Hetil; 1979 Jan; 120(2):79-82. PubMed ID: 760038
[No Abstract] [Full Text] [Related]
29. Antitumor effects of ricin A chain immunotoxins prepared from intact antibodies and Fab' fragments on solid human Hodgkin's disease tumors in mice.
Engert A; Martin G; Pfreundschuh M; Amlot P; Hsu SM; Diehl V; Thorpe P
Cancer Res; 1990 May; 50(10):2929-35. PubMed ID: 1692251
[TBL] [Abstract][Full Text] [Related]
30. Covalent binding of C3b to monoclonal antibodies selectively up-regulates heavy chain epitope recognition by T cells.
Santoro L; Drouet C; Reboul A; Mach JP; Colomb MG
Eur J Immunol; 1994 Jul; 24(7):1620-6. PubMed ID: 8026522
[TBL] [Abstract][Full Text] [Related]
31. Presence of complement-fixing antibodies against antigens of Gross virus-induced rat lymphoma and normal rat thymus in sera of patients with some forms of malignancies.
Simkovic D; Chorváth B; Hlubinová K; Valentová N; Stevonková J; Babusíková O; Simkovicová M
Neoplasma; 1977; 24(4):357-63. PubMed ID: 269322
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's disease.
Engert A; Burrows F; Jung W; Tazzari PL; Stein H; Pfreundschuh M; Diehl V; Thorpe P
Cancer Res; 1990 Jan; 50(1):84-8. PubMed ID: 2152774
[TBL] [Abstract][Full Text] [Related]
33. Isolation of autologous antibodies to antigens-associated with Hodgkin's disease.
Dölken G; Löhr GW
Biomedicine; 1980; 33(5):163-7. PubMed ID: 7002227
[TBL] [Abstract][Full Text] [Related]
34. Absence of IgG lymphocytotoxins in untreated Hodgkin's disease (HD) patients.
Jones DB; Elliott EV; Payne SV; Wright DH
Clin Exp Immunol; 1978 Oct; 34(1):100-5. PubMed ID: 750114
[TBL] [Abstract][Full Text] [Related]
35. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
36. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
Bieber MM; Fuks Z; Kaplan HS
Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
[TBL] [Abstract][Full Text] [Related]
37. Circulating immune complexes and complement activation in primary biliary cirrhosis.
Wands JR; Dienstag JL; Bhan AK; Feller ER; Isselbacher KJ
N Engl J Med; 1978 Feb; 298(5):233-7. PubMed ID: 619265
[TBL] [Abstract][Full Text] [Related]
38. [New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?].
Engert A; Gottstein C; Winkler U; Schön G; Amlot P; Thorpe P; Diehl V
Med Klin (Munich); 1992 Oct; 87(10):503-9. PubMed ID: 1461215
[TBL] [Abstract][Full Text] [Related]
39. Characterization of immune complexes and immunoglobulin G antibodies reactive with neutrophils in the sera of patients with Felty's syndrome.
Starkebaum G; Arend WP; Nardella FA; Gavin SE
J Lab Clin Med; 1980 Aug; 96(2):238-51. PubMed ID: 6772719
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of immune precipitation by complement.
Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
